CAPTRUST Financial Advisors’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Other funds holding XERS
CAPTRUST Financial Advisors's XERS Position: Q3 2026 in Review
CAPTRUST Financial Advisors increased its Xeris Biopharma Holdings (XERS) stake by 12% in Q3 2026, buying an estimated $19.5K and bringing the position to 22,303 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #2932.
CAPTRUST Financial Advisors first reported a position in XERS in Q1 2021 and has held it in 10 quarters since. 248 funds tracked by Wall St. Rank hold XERS as of Q3 2026.
- CAPTRUST Financial Advisors held 22,303 shares of Xeris Biopharma Holdings worth $213K as of Q3 2026.
- CAPTRUST Financial Advisors bought 2,310 Xeris Biopharma Holdings shares in Q3 2026, an estimated $19.5K.
- Xeris Biopharma Holdings made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q3 2026, its #2932 holding.
- CAPTRUST Financial Advisors first reported a position in Xeris Biopharma Holdings in Q1 2021 and has held it in 10 quarters since.
- 248 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.